In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Atrial Fibrillation & the risk of Stroke

ESC Congress 2014, Barcelona - press conference

Date & Time:  Tuesday 02 September, 13:00-14:00

Chairpersons
Prof. John Camm (UK)
Dr Fernando Arribas (Spain)
Spokespersons
Prof. Marten Rosenqvist (Sweden)
Prof. Antoni Martinez-Rubio (Spain)
Prof. Marteen Simoons (Netherlands)

 

 



The French screening campaign of atrial fibrillation in general practice: assessment of predictive criteria for atrial fibrillation

Prof. Jean-Marc Davy, Hopital Arnaud de Villeneuve (France)
Refers to abstract: The French screening campaign of atrial fibrillation in general practice: assessment of predictive criteria for atrial fibrillation
Press release  |  Slides

 

 

Risk of ischemic stroke or systemic embolism in aspirin-treated patients according to clinical presentation of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE or AVERROES

Dr Thomas Vanassche, University of Leuven (Leuven, Belgium)
Refers to abstract: Risk of ischemic stroke or systemic embolism in aspirin-treated patients according to clinical presentation of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE or AVERROES
Press release  |  Slides

 

 

Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience

Dr Alexandr Romanov, State Research Institute of Circulation Pathology (Novosibirsk, Russia)
Refers to abstract: Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience
Press release  |  Slides

 

 

Digoxin use in patients with atrial fibrillation is associated with adverse cardiac outcomes: results from the ROCKET AF trial

Dr Manesh Patel, Duke Clinical Research Institute (USA)
Refers to abstract: Digoxin use in patients with atrial fibrillation is associated with adverse cardiac outcomes: results from the ROCKET AF trial
Press release  |  Slides

 

 



Abstracts linked to ESC press conferences are not available until embargo lifts. The embargo lifts at the beginning of the press conference or the scientific session, whichever comes first. All other abstracts will be online on 22 August, 2014 in the Scientific Programme Planner except for Hot Lines, Clinical Trial Update and Registries Hot Lines abstracts.
Press releases are available on site in the press kit (USB key) that you will receive once you pick up your badge at the press registration desk at ESC Congress 2014 - except for press releases on Clinical Trial Updates and Hot Line sessions which are only available when the embargo lifts.
Press slides will be available at the beginning of the press conference.
All ESC Press conferences will be broadcasted live. Unfortunately, no webcast will be available. Access to the session will be restricted to registered press only.
During the ESC Congress 2014, all scientific resources are available on ESC Congress 365.